Literature DB >> 1331090

Purification and characterization of Rac 2. A cytosolic GTP-binding protein that regulates human neutrophil NADPH oxidase.

U G Knaus1, P G Heyworth, B T Kinsella, J T Curnutte, G M Bokoch.   

Abstract

Human neutrophils and other phagocytes generate superoxide anion (O2-) as a means of destroying ingested microorganisms. O2- is produced by an NADPH-consuming oxidase composed of membrane and cytosolic components. Activation of the NADPH oxidase is absolutely dependent upon GTP, indicating the requirement for a GTP-binding protein in this process. We have utilized a five-step chromatographic procedure to isolate a GTP-binding protein from human neutrophil cytosol which can stimulate NADPH oxidase activity in a cell-free assay. Oxidase enhancing activity was shown to coisolate with this GTP-binding component, which was purified to apparent homogeneity. The GTP-binding protein was identified as Rac 2 by immunological reactivity and amino acid sequencing. Thus, Rac 2 appears to be a third cytosolic component required for human neutrophil NADPH oxidase activation. Recombinant Rac 2 was shown to bind guanine nucleotides in a Mg(2+)-dependent fashion. GDP dissociation rates were determined and shown to be regulated by the free Mg2+ concentration. Rac 2 was found to possess the highest rate of intrinsic GTP hydrolysis of any of the characterized members of the Ras superfamily. The biochemical properties of Rac 2 indicate it is likely to be subject to regulatory cofactors in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331090

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.

Authors:  F C Yang; S J Atkinson; Y Gu; J B Borneo; A W Roberts; Y Zheng; J Pennington; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Deactivation of neutrophil NADPH oxidase by actin-depolymerizing agents in a cell-free system.

Authors:  M Tamura; M Kanno; Y Endo
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 3.  Assembly of the phagocyte NADPH oxidase.

Authors:  William M Nauseef
Journal:  Histochem Cell Biol       Date:  2004-08-04       Impact factor: 4.304

4.  The small G protein Rac1 activates phospholipase Cdelta1 through phospholipase Cbeta2.

Authors:  Yuanjian Guo; Urszula Golebiewska; Stephen D'Amico; Suzanne Scarlata
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

5.  Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.

Authors:  Veronique Daniëls; Renée Vancraenenbroeck; Bernard M H Law; Elisa Greggio; Evy Lobbestael; Fangye Gao; Marc De Maeyer; Mark R Cookson; Kirsten Harvey; Veerle Baekelandt; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

6.  Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function.

Authors:  Jon M Davis; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family.

Authors:  T H Chuang; X Xu; V Kaartinen; N Heisterkamp; J Groffen; G M Bokoch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Mechanism of Cdc42-induced actin polymerization in neutrophil extracts.

Authors:  S H Zigmond; M Joyce; C Yang; K Brown; M Huang; M Pring
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

Review 9.  Mechanisms for the activation/electron transfer of neutrophil NADPH-oxidase complex and molecular pathology of chronic granulomatous disease.

Authors:  S Umeki
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

10.  A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.

Authors:  J H Leusen; M de Boer; B G Bolscher; P M Hilarius; R S Weening; H D Ochs; D Roos; A J Verhoeven
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.